Polymeric nano-encapsulation of 5-fluorouracil enhances anti-cancer activity and ameliorates side effects in solid Ehrlich Carcinoma-bearing mice
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 105, 215-224
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Polymeric nanoparticles for oral delivery of 5-fluorouracil: Formulation optimization, cytotoxicity assay and pre-clinical pharmacokinetics studyEuropean Journal of Pharmaceutical Sciences, 2016
- Synthesis and Characterization of Al(OH)3, Al2O3 Nanoparticles and Polymeric NanocompositesJournal of Cluster Science, 2015
- PEGylated-PLGA microparticles containing VEGF for long term drug deliveryInternational Journal of Pharmaceutics, 2013
- Biodegradable PLGA-b-PEG polymeric nanoparticles: synthesis, properties, and nanomedical applications as drug delivery systemJournal of Nanoparticle Research, 2012
- Influence of some physical properties of 5-fluorouracil on encapsulation efficiency in liposomesJournal of Thermal Analysis and Calorimetry, 2011
- Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(d, l-lactide) (PLA) based nanoparticlesEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Translocator protein (18 kDa) mediates the pro-growth effects of diazepam on Ehrlich tumor cells in vivoEuropean Journal of Pharmacology, 2010
- Poly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular DeliveryPharmaceutical Research, 2007
- PLA/PLGA nanoparticles for sustained release of docetaxelInternational Journal of Pharmaceutics, 2006
- Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticlesInternational Journal of Pharmaceutics, 2006